PIERIS PHARMACEUTICALS, INC. - FORM 10-K - EX-32.2 - March 29, 2017

Attached files

file filename
EX-32.1 - EX-32.1 - PIERIS PHARMACEUTICALS, INC.d325265dex321.htm
EX-31.2 - EX-31.2 - PIERIS PHARMACEUTICALS, INC.d325265dex312.htm
EX-31.1 - EX-31.1 - PIERIS PHARMACEUTICALS, INC.d325265dex311.htm
EX-23.2 - EX-23.2 - PIERIS PHARMACEUTICALS, INC.d325265dex232.htm
EX-23.1 - EX-23.1 - PIERIS PHARMACEUTICALS, INC.d325265dex231.htm
EX-21.1 - EX-21.1 - PIERIS PHARMACEUTICALS, INC.d325265dex211.htm
EX-10.30 - EX-10.30 - PIERIS PHARMACEUTICALS, INC.d325265dex1030.htm
EX-10.29 - EX-10.29 - PIERIS PHARMACEUTICALS, INC.d325265dex1029.htm
EX-10.28 - EX-10.28 - PIERIS PHARMACEUTICALS, INC.d325265dex1028.htm
EX-10.26 - EX-10.26 - PIERIS PHARMACEUTICALS, INC.d325265dex1026.htm
EX-10.16 - EX-10.16 - PIERIS PHARMACEUTICALS, INC.d325265dex1016.htm
EX-10.15 - EX-10.15 - PIERIS PHARMACEUTICALS, INC.d325265dex1015.htm
EX-10.14 - EX-10.14 - PIERIS PHARMACEUTICALS, INC.d325265dex1014.htm
EX-10.4 - EX-10.4 - PIERIS PHARMACEUTICALS, INC.d325265dex104.htm
10-K - 10-K - PIERIS PHARMACEUTICALS, INC.d325265d10k.htm

Exhibit 32.2

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Pieris Pharmaceuticals, Inc., a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report for the year ended December 31, 2016 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 29, 2017    

/s/ Lance Thibault

    Lance Thibault
    Title:   Acting Chief Financial Officer
      (principal financial officer)

PIERIS PHARMACEUTICALS, INC. Reports